Overview

  • Product nameAnti-p21 antibodySee all p21 primary antibodies ...
  • Description
    Rabbit polyclonal to p21
  • SpecificityDetects a clean band at 21kDa corresponding to p21, as well as a cross-reacting band at 26kDa.
  • Tested applicationsICC/IF, Sandwich ELISA, WB, IHC-Pmore details
  • Species reactivity
    Reacts with: Rat, Cow, Human
    Predicted to work with: Cat, Dog
  • Immunogen

    Synthetic peptide conjugated to KLH derived from within residues 100 to the C-terminus of Human p21.

    (Peptide available as ab18623.)

  • Positive control
    • This antibody gave a positive signal in the following whole cell lysates: HeLa; Hela - Bleomycin Treated (40U/ml); HeLa Whole - Irradiated (5Gy); Hela - Hydroxyurea Treated (48hr, 1uM); PC12.

Properties

Applications

Our Abpromise guarantee covers the use of ab18209 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
ICC/IF Use a concentration of 5 µg/ml.
Sandwich ELISA Use a concentration of 0.5 µg/ml. Can be paired for Sandwich ELISA with Mouse monoclonal [AC8.3] to p21 (ab118). For sandwich ELISA, use this antibody as Detection at 0.5µg/ml with Ab118 as Capture.
WB Use a concentration of 1 µg/ml. Detects a band of approximately 21 kDa (predicted molecular weight: 21 kDa).Can be blocked with Human p21 peptide (ab18623).
IHC-P Use at an assay dependent concentration. Perform heat mediated antigen retrieval before commencing with IHC staining protocol.

Target

  • FunctionMay be the important intermediate by which p53/TP53 mediates its role as an inhibitor of cellular proliferation in response to DNA damage. Binds to and inhibits cyclin-dependent kinase activity, preventing phosphorylation of critical cyclin-dependent kinase substrates and blocking cell cycle progression. Functions in the nuclear localization and assembly of cyclin D-CDK4 complex and promotes its kinase activity towards RB1. At higher stoichiometric ratios, inhibits the kinase activity of the cyclin D-CDK4 complex.
  • Tissue specificityExpressed in all adult human tissues, with 5-fold lower levels observed in the brain.
  • Sequence similaritiesBelongs to the CDI family.
  • DomainThe PIP-box K+4 motif mediates both the interaction with PCNA and the recuitment of the DCX(DTL) complex: while the PIP-box interacts with PCNA, the presence of the K+4 submotif, recruits the DCX(DTL) complex, leading to its ubiquitination.
    The C-terminal is required for nuclear localization of the cyclin D-CDK4 complex.
  • Post-translational
    modifications
    Phosphorylation of Thr-145 by Akt or of Ser-146 by PKC impairs binding to PCNA. Phosphorylation at Ser-114 by GSK3-beta enhances ubiquitination by the DCX(DTL) complex.
    Ubiquitinated by MKRN1; leading to polyubiquitination and 26S proteasome-dependent degradation. Ubiquitinated by the DCX(DTL) complex, also named CRL4(CDT2) complex, leading to its degradation during S phase or following UV irradiation. Ubiquitination by the DCX(DTL) complex is essential to control replication licensing and is PCNA-dependent: interacts with PCNA via its PIP-box, while the presence of the containing the 'K+4' motif in the PIP box, recruit the DCX(DTL) complex, leading to its degradation.
  • Cellular localizationCytoplasm. Nucleus.
  • Information by UniProt
  • Database links
  • Alternative names
    • Activating Fragment 1 antibody
    • Activating Fragment 1 antibody
    • CAP20 antibody
    • CAP20 antibody
    • Cation chloride cotransporter-interacting protein 1 antibody
    • CDK Interacting Protein 1 antibody
    • CDK Interacting Protein 1 antibody
    • CDK-interacting protein 1 antibody
    • CDKI antibody
    • CDKN 1 antibody
    • CDKN1 antibody
    • CDKN1 antibody
    • CDKN1A antibody
    • CDKN1A antibody
    • CDN1A_HUMAN antibody
    • CIP1 antibody
    • CIP1 antibody
    • Cyclin Dependent Kinase Inhibitor 1A antibody
    • Cyclin Dependent Kinase Inhibitor 1A antibody
    • Cyclin-dependent kinase inhibitor 1 antibody
    • Cyclin-dependent kinase inhibitor 1A (P21) antibody
    • Cyclin-dependent kinase inhibitor 1A (p21, Cip1) antibody
    • DNA Synthesis Inhibitor antibody
    • MDA 6 antibody
    • MDA-6 antibody
    • MDA6 antibody
    • MDA6 antibody
    • Melanoma Differentiation Associated Protein 6 antibody
    • Melanoma differentiation-associated protein 6 antibody
    • Melanoma differentiation-associated protein antibody
    • p21 antibody
    • p21 antibody
    • P21 protein antibody
    • p21CIP1 antibody
    • p21Cip1/Waf1 antibody
    • p21WAF antibody
    • PIC1 antibody
    • PIC1 antibody
    • SDI1 antibody
    • SDI1 antibody
    • SLC12A9 antibody
    • WAF1 antibody
    • WAF1 antibody
    • Wild type p53 activated fragment 1 antibody
    • Wildtype p53 Activating Fragment 1 antibody
    • Wildtype p53 Activating Fragment 1 antibody
    • Wildtype p53-activated fragment 1 antibody
    see all

Anti-p21 antibody images

  • IHC image of p21 staining in human lung FFPE section, performed on a BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab18209, 5ug/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

  • ab18209 staining p21 in serum starved PC-3 cells treated with β-lapachone (ab141097), by ICC/IF. Increase of p21 nuclear expression correlates with increased concentration of β-lapachone, as described in literature.
    The cells were incubated at 37°C for 6 hours in media containing different concentrations of ab141097 (β-lapachone) in DMSO, fixed with 100% methanol for 5 minutes at -20°C and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab18209 (5 µg/ml) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight 488 anti-rabbit polyclonal antibody (ab96899) at 1/250 dilution was used as the secondary antibody. Nuclei were counterstained with DAPI and are shown in blue.
  • ICC/IF image of ab18209 stained human HeLa cells. The cells were methanol fixed (5 min) and incubated with the antibody (ab18209, 1µg/ml) for 1h at room temperature. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Image-iTTM FX Signal Enhancer was used as the primary blocking agent, 5% BSA (in TBS-T) was used for all other blocking steps. DAPI was used to stain the cell nuclei (blue). Alexa Fluor® 594 WGA was used to label plasma membranes (red).

  • The image shows staining of human embryonic stem cells with ab18209. Staining appears to be nuclear.
  • All lanes : Anti-p21 antibody (ab18209) at 1 µg/ml

    Lane 1 : HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate
    Lane 2 : HeLa Whole Cell Lysate - Irradiated (5Gy)
    Lane 3 : PC12 (Rat adrenal pheochromocytoma cell line) Whole Cell Lysate

    Lysates/proteins at 10 µg per lane.

    Secondary
    Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/50000 dilution
    developed using the ECL technique

    Performed under reducing conditions.

    Predicted band size : 21 kDa
    Observed band size : 21 kDa


    Exposure time : 30 seconds

    This blot was produced using a 4-12% Bis-tris gel under the MES buffer system. The gel was run at 200V for 35 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 2% Bovine Serum Albumin before being incubated with ab18209 overnight at 4°C. Antibody binding was detected using an anti-rabbit antibody conjugated to HRP, and visualised using ECL development solution ab133406

  • Anti-p21 antibody (ab18209) at 1 µg/ml + HeLa whole cell lysate at 20 µg/ml

    Secondary
    Alexa Fluor Goat polyclonal to Rabbit IgG (700) at 1/10000 dilution

    Predicted band size : 21 kDa
    Observed band size : 21 kDa
    Additional bands at : 26 kDa (possible cross reactivity).
  • All lanes : Anti-p21 antibody (ab18209) at 1 µg/ml

    Lane 1 : HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate
    Lane 2 : Hela Whole Cell Lysate - Bleomycin Treated (40U/ml)
    Lane 3 : HeLa Whole Cell Lysate - Irradiated (5Gy)
    Lane 4 : Hela Whole Cell Lysate - Hydroxyurea Treated (48hr, 1uM)

    Lysates/proteins at 20 µg per lane.

    Secondary
    Goat polyclonal to Rabbit IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution
    developed using the ECL technique

    Performed under reducing conditions.

    Predicted band size : 21 kDa
    Observed band size : 21 kDa
    Additional bands at : 36 kDa,56 kDa. We are unsure as to the identity of these extra bands.

    Exposure time : 20 minutes
  • Standard curve for p21 (Analyte: ab56278); dilution range 1pg/ml to 1µg/ml using Capture Antibody Mouse monoclonal [AC8.3] to p21 (ab118) at 5µg/ml and Detector Antibody Rabbit polyclonal to p21 (ab18209) at 0.5µg/ml.
  • Anti-p21 antibody (ab18209) at 1 µg/ml + Human p21 full length protein (ab56278) at 0.01 µg

    Secondary
    Goat polyclonal to Rabbit IgG - H&L - Pre-Adsorbed (HRP) (ab65484) at 1/5000 dilution
    developed using the ECL technique

    Performed under reducing conditions.

    Predicted band size : 21 kDa


    Exposure time : 150 seconds
    ab56278 is a tagged recombinant protein, with a predicted molecular weight of 46kDa.

Protocols

References for Anti-p21 antibody (ab18209)

This product has been referenced in:
  • Wang M  et al. EGFR-mediated chromatin condensation protects KRAS-mutant cancer cells against ionizing radiation. Cancer Res 74:2825-34 (2014). WB ; Human . Read more (PubMed: 24648348) »
  • Sousa MM  et al. An inverse switch in DNA base excision and strand break repair contributes to melphalan resistance in multiple myeloma cells. PLoS One 8:e55493 (2013). WB ; Human . Read more (PubMed: 23405159) »

See all 3 Publications for this product

Product Wall

Thank you for your reply.

While I did not receive the image which you have referenced I would like to offer so help regarding your questions. Generally specific details regarding secondary antibody incubation and concentration as will need...

Read More

Thank you for your reply.

Thank you for helping my confusion about which image we were discussing. This information does help to understand the results you are getting with this product. These non specific bands have not been identified ho...

Read More

Thank you for contacting us.

I will forward your questions to the lab. However I can answer a few. We used 20ug/well of protein. Our standard protocol is to run transfers run wet or semi-dry for 40minutes to 1 hour. Generally we use chemil...

Read More

Thank you for contacting Abcam.

I am very sorry to hear that you have been experiencing difficulties when using this product with the recommended HeLa whole cell lysate positive control. We have achieved best results when using this antibody...

Read More

Thank you for contacting Abcam and it was good to meet you at the Distributor Day events.

I have looked through our catalogue to try and find some antibodies that would match your customers needs and I have placed links to the best matches bel...

Read More

Thank you for your phone call.


DISCOUNT CODE: xxx
Expiration date: xxx

I am very pleased to hear you would like to accept our offer and test ab18209 in sheep. This code will give you 1 free PRIMARY ANTIBODYbefore the exp...

Read More
Application Western blot
Sample Cow Cell lysate - whole cell (aortic endothelial cells)
Loading amount 20 µg
Specification aortic endothelial cells
Treatment 10uM 4HNE for 5 days
Gel Running Conditions Reduced Denaturing (15% gel)
Blocking step Milk as blocking agent for 2 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 22°C
Username

Abcam user community

Verified customer

Submitted Feb 03 2011

Application Immunocytochemistry/ Immunofluorescence
Sample Human Cell (Fibroblasts)
Specification Fibroblasts
Fixative Paraformaldehyde
Permeabilization Yes - 0.5% Triton-X
Blocking step BSA as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 1% · Temperature: 21°C
Username

Abcam user community

Verified customer

Submitted May 25 2010

Application Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)
Sample Human Tissue sections (Skin, verruca vulgaris (wart))
Specification Skin, verruca vulgaris (wart)
Fixative Formaldehyde
Antigen retrieval step Heat mediated - Buffer/Enzyme Used: Citrate buffer pH 6.0
Permeabilization Yes - TBST
Blocking step BSA as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 2% · Temperature: 22°C
Username

Abcam user community

Verified customer

Submitted Feb 16 2010

Thank you for contacting us for technical support, I'm sorry to hear you are having problems with ab18209 and am worried the high band you are seeing is the non specific band we see at 29kda (please see image). I cannot offer you a free sample of th...

Read More

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"